Delayed
Japan Exchange
06:02:22 28/05/2024 BST
|
5-day change
|
1st Jan Change
|
1,039
JPY
|
+0.29%
|
|
-4.85%
|
-17.01%
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
309,107
|
268,647
|
357,394
|
269,851
|
208,680
|
124,751
|
-
|
-
|
Enterprise Value (EV)
1 |
290,074
|
249,501
|
332,542
|
247,265
|
157,805
|
116,803
|
124,751
|
124,751
|
P/E ratio
|
84.5
x
|
70.3
x
|
37.4
x
|
13.6
x
|
13
x
|
78.9
x
|
34.1
x
|
29.1
x
|
Yield
|
0.27%
|
0.36%
|
0.54%
|
1.47%
|
2.42%
|
1.75%
|
1.74%
|
1.93%
|
Capitalization / Revenue
|
8.62
x
|
7.77
x
|
7.75
x
|
3.99
x
|
2.67
x
|
2.68
x
|
2.63
x
|
2.47
x
|
EV / Revenue
|
8.62
x
|
7.77
x
|
7.75
x
|
3.99
x
|
2.67
x
|
2.68
x
|
2.63
x
|
2.47
x
|
EV / EBITDA
|
35.7
x
|
27.7
x
|
20.2
x
|
8.19
x
|
8.28
x
|
14.7
x
|
13.3
x
|
12
x
|
EV / FCF
|
1,493
x
|
114
x
|
35.2
x
|
-3,138
x
|
6.91
x
|
-18
x
|
15.6
x
|
76
x
|
FCF Yield
|
0.07%
|
0.88%
|
2.84%
|
-0.03%
|
14.5%
|
-5.54%
|
6.42%
|
1.32%
|
Price to Book
|
4.83
x
|
4.04
x
|
4.82
x
|
2.81
x
|
1.86
x
|
1.05
x
|
1.11
x
|
1.1
x
|
Nbr of stocks (in thousands)
|
120,416
|
120,416
|
120,416
|
120,416
|
120,416
|
120,416
|
-
|
-
|
Reference price
2 |
2,567
|
2,231
|
2,968
|
2,241
|
1,733
|
1,036
|
1,036
|
1,036
|
Announcement Date
|
14/05/19
|
14/05/20
|
13/05/21
|
12/05/22
|
11/05/23
|
10/05/24
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
35,841
|
34,565
|
46,086
|
67,699
|
78,142
|
43,505
|
47,412
|
50,546
|
EBITDA
1 |
8,656
|
9,691
|
17,658
|
32,956
|
25,190
|
7,922
|
9,403
|
10,394
|
EBIT
1 |
5,463
|
6,274
|
13,952
|
28,902
|
20,541
|
3,003
|
5,070
|
5,946
|
Operating Margin
|
15.24%
|
18.15%
|
30.27%
|
42.69%
|
26.29%
|
6.9%
|
10.69%
|
11.76%
|
Earnings before Tax (EBT)
1 |
4,823
|
5,433
|
13,552
|
27,532
|
21,224
|
2,853
|
5,066
|
5,963
|
Net income
1 |
3,657
|
3,819
|
9,547
|
19,849
|
16,012
|
1,480
|
3,658
|
4,284
|
Net margin
|
10.2%
|
11.05%
|
20.72%
|
29.32%
|
20.49%
|
3.4%
|
7.72%
|
8.47%
|
EPS
2 |
30.38
|
31.72
|
79.29
|
164.8
|
133.0
|
12.30
|
30.38
|
35.58
|
Free Cash Flow
1 |
207
|
2,356
|
10,165
|
-86
|
30,204
|
-6,914
|
8,006
|
1,642
|
FCF margin
|
0.58%
|
6.82%
|
22.06%
|
-0.13%
|
38.65%
|
-15.43%
|
16.89%
|
3.25%
|
FCF Conversion (EBITDA)
|
2.39%
|
24.31%
|
57.57%
|
-
|
119.9%
|
-
|
85.14%
|
15.8%
|
FCF Conversion (Net income)
|
5.66%
|
61.69%
|
106.47%
|
-
|
188.63%
|
-
|
218.86%
|
38.34%
|
Dividend per Share
2 |
7.000
|
8.000
|
16.00
|
33.00
|
42.00
|
17.00
|
18.00
|
20.00
|
Announcement Date
|
14/05/19
|
14/05/20
|
13/05/21
|
12/05/22
|
11/05/23
|
10/05/24
|
-
|
-
|
Fiscal Period: March |
2020 S1
|
2020 S2
|
2021 S1
|
2021 S2
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2022 S2
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2023 S2
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
2024 S2
|
2025 Q1
|
2025 Q2
|
2025 S1
|
2025 Q3
|
2025 Q4
|
2025 S2
|
---|
Net sales
1 |
16,450
|
18,115
|
17,393
|
28,693
|
16,279
|
31,551
|
14,108
|
22,040
|
36,148
|
14,102
|
18,485
|
32,587
|
27,619
|
17,936
|
45,555
|
9,176
|
9,940
|
19,116
|
10,618
|
13,771
|
24,389
|
9,594
|
10,274
|
19,868
|
11,323
|
15,231
|
26,553
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
3,035
|
3,239
|
3,736
|
-
|
5,601
|
14,105
|
5,821
|
8,976
|
14,797
|
4,537
|
6,333
|
10,870
|
8,533
|
1,138
|
9,671
|
423
|
987
|
1,410
|
-1,074
|
2,667
|
1,593
|
-175
|
819
|
644
|
913
|
2,586
|
3,499
|
Operating Margin
|
18.45%
|
17.88%
|
21.48%
|
-
|
34.41%
|
44.71%
|
41.26%
|
40.73%
|
40.93%
|
32.17%
|
34.26%
|
33.36%
|
30.9%
|
6.34%
|
21.23%
|
4.61%
|
9.93%
|
7.38%
|
-10.11%
|
19.37%
|
6.53%
|
-1.82%
|
7.97%
|
3.24%
|
8.06%
|
16.98%
|
13.18%
|
Earnings before Tax (EBT)
1 |
2,950
|
2,483
|
3,281
|
-
|
5,642
|
14,203
|
5,911
|
7,418
|
13,329
|
5,479
|
6,352
|
11,831
|
8,487
|
906
|
9,393
|
505
|
1,083
|
1,588
|
-1,088
|
2,353
|
1,265
|
-259
|
734
|
475
|
822
|
2,519
|
3,341
|
Net income
1 |
2,075
|
1,744
|
2,274
|
-
|
3,984
|
10,009
|
4,355
|
5,485
|
9,840
|
3,907
|
4,631
|
8,538
|
6,057
|
1,417
|
7,474
|
319
|
765
|
1,084
|
-930
|
1,326
|
396
|
-539
|
454
|
-85
|
542
|
2,239
|
2,781
|
Net margin
|
12.61%
|
9.63%
|
13.07%
|
-
|
24.47%
|
31.72%
|
30.87%
|
24.89%
|
27.22%
|
27.71%
|
25.05%
|
26.2%
|
21.93%
|
7.9%
|
16.41%
|
3.48%
|
7.7%
|
5.67%
|
-8.76%
|
9.63%
|
1.62%
|
-5.62%
|
4.42%
|
-0.43%
|
4.79%
|
14.7%
|
10.47%
|
EPS
2 |
17.23
|
14.49
|
18.89
|
-
|
33.08
|
83.12
|
36.17
|
45.55
|
81.72
|
32.45
|
38.46
|
70.91
|
50.30
|
11.76
|
62.06
|
2.650
|
6.350
|
9.000
|
-7.720
|
11.02
|
3.300
|
-4.500
|
3.800
|
-0.7000
|
4.500
|
18.60
|
23.10
|
Dividend per Share
2 |
-
|
8.000
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
12.00
|
12.00
|
-
|
-
|
-
|
-
|
-
|
17.00
|
Announcement Date
|
12/11/19
|
14/05/20
|
10/11/20
|
13/05/21
|
09/11/21
|
09/11/21
|
10/02/22
|
12/05/22
|
12/05/22
|
04/08/22
|
10/11/22
|
10/11/22
|
09/02/23
|
11/05/23
|
11/05/23
|
08/08/23
|
09/11/23
|
09/11/23
|
14/02/24
|
10/05/24
|
10/05/24
|
-
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
19,033
|
19,146
|
24,852
|
22,586
|
50,875
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
207
|
2,356
|
10,165
|
-86
|
30,204
|
-6,914
|
8,006
|
1,643
|
ROE (net income / shareholders' equity)
|
5.8%
|
5.9%
|
13.6%
|
23.3%
|
15.4%
|
1.3%
|
3.22%
|
3.63%
|
ROA (Net income/ Total Assets)
|
8.1%
|
8.69%
|
17.2%
|
27.7%
|
16.9%
|
2.72%
|
5%
|
-
|
Assets
1 |
45,154
|
43,939
|
55,546
|
71,651
|
94,806
|
54,431
|
73,160
|
-
|
Book Value Per Share
2 |
532.0
|
552.0
|
616.0
|
796.0
|
932.0
|
926.0
|
930.0
|
941.0
|
Cash Flow per Share
2 |
54.20
|
56.90
|
107.0
|
195.0
|
167.0
|
48.70
|
77.40
|
86.60
|
Capex
1 |
6,002
|
3,983
|
8,673
|
12,356
|
5,747
|
14,500
|
10,000
|
6,000
|
Capex / Sales
|
16.75%
|
11.52%
|
18.82%
|
18.25%
|
7.35%
|
32.35%
|
21.09%
|
11.87%
|
Announcement Date
|
14/05/19
|
14/05/20
|
13/05/21
|
12/05/22
|
11/05/23
|
10/05/24
|
-
|
-
|
Last Close Price
1,036
JPY Average target price
1,567
JPY Spread / Average Target +51.22% Consensus |
1st Jan change
|
Capi.
|
---|
| -17.01% | 796M | | +67.53% | 63.85B | | -0.77% | 41.83B | | +44.98% | 40.47B | | -10.87% | 27.17B | | +13.30% | 26.52B | | -22.79% | 18.69B | | +4.70% | 12.73B | | +24.10% | 12.11B | | +27.41% | 12.07B |
Other Biotechnology & Medical Research
|